Having trouble viewing this email? View it as a Web page.
What’s New at CBER
You are subscribed to What’s New at CBER for the U.S. Food & Drug Administration (FDA).
This page has been updated recently.
- Darwin Life, Inc. – Untitled Letter (PDF – 32KB)
- Advisory on Legal Restrictions on the Use of Mitochondrial Replacement Techniques to Introduce Donor Mitochondria into Reproductive Cells Intended for Transfer into a Human Recipient